Bausch Health Companies Inc. (BHC)
Data as of , from SEC Form 4 filings.
See up to 3 months of BHC. The 7-day demo opens the 1M and 3M ranges and puts BHC on your watchlist.
Start 7-day demoLatest BHC insider trades
- Aimee J. Lenar - OfficerOpen-market sale$259K
- Frank D. Lee - DirectorOpen-market sale$133K
Seana Carson
About Bausch Health Companies Inc. (BHC)
The SEC lists Bausch Health Companies Inc. under CIK 0000885590, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
BHC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 36,827 | $259K |
| Grant or award | 3 | 17,688 | |
| Tax withholding / forfeiture | 2 | 28,655 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BHC insider transactions (Form 4)
3157 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas Appio - Officer | Grant or award | Common Shares, No Par Value | 815,425 footnote F1 | $0.00 | - | |
| Thomas Appio - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 116,502 footnote F2 | $6.04 | $704K | |
| ||||||
| Thomas Appio - Officer | Grant or award | Common Shares, No Par Value | 1,137,862 footnote F1 | $0.00 | - | |
| ||||||
| Seana Carson - Officer | Grant or award | Common Shares, No Par Value | 137,922 footnote F1 | $0.00 | - | |
| ||||||
 John Paulson - Director | Grant or award | Common Shares, No Par Value | 8,992 | $0.00 | - | |
| Sandra Leung - Director | Grant or award | Common Shares, No Par Value | 4,586 | $0.00 | - | |
| Amy B. Wechsler - Director | Grant or award | Common Shares, No Par Value | 989 | $0.00 | - | |
| PAULSON CO. INC. | Open-market purchase | Common Stock, no par value | 2,500,000 | $6.25 | $15.63M | |
| Amy B. Wechsler - Director | Grant or award | Common Shares, No Par Value | 1,065 | $0.00 | - | |
| Sandra Leung - Director | Grant or award | Common Shares, No Par Value | 3,673 | $0.00 | - | |
| Seana Carson - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 51,337 | $7.35 | $377K | |
| Seana Carson - Officer | Open-market sale | Common Shares, No Par Value | 13,370 | $7.31 | $98K | |
| Frank D. Lee - Director | Open-market sale | Common Shares, No Par Value | 15,912 | $7.66 | $122K | |
| John Paulson | Open-market purchase | Common Stock, no par value | 34,721,118 | $9.00 | $312.49M | |
| John Paulson | Open-market purchase | Common Stock, no par value | 2,000,000 | $6.35 | $12.70M | |
| John Paulson | Open-market purchase | Common Stock, no par value | 1,156,640 | $6.88 | $7.96M | |
| John Paulson | Open-market purchase | Common Stock, no par value | 86,409 | $7.06 | $610K | |
| Michael Goettler - Director | Grant or award | Common Shares, No Par Value | 30,149 | $0.00 | - | |
| Sandra Leung - Director | Grant or award | Common Shares, No Par Value | 30,149 | $0.00 | - | |
| Aimee J. Lenar - Officer | Grant or award | Common Shares, No Par Value | 30,847 | $0.00 | - | |
| Aimee J. Lenar - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 22,736 | $6.42 | $146K | |
| Steven Hyosig Lee - Officer | Grant or award | Common Shares, No Par Value | 27,371 | $0.00 | - | |
| Amy B. Wechsler - Director | Grant or award | Common Shares, No Par Value | 1,032 | $0.00 | - | |
| John Paulson - Director | Grant or award | Common Shares, No Par Value | 9,384 | $0.00 | - | |
| Brett Icahn - Director | Grant or award | Common Shares, No Par Value | 4,034 | $0.00 | - | |
| Robert N. Power - Director | Grant or award | Common Shares, No Par Value | 54,347 | $0.00 | - | |
| Seana Carson - Officer | Tax withholding / forfeiture | Common Shares, No Par Value | 1,692 | $8.37 | $14K | |
| Seana Carson - Officer | Open-market sale | Common Shares, No Par Value | 440 | $8.35 | $4K | |
| Amy B. Wechsler - Director | Grant or award | Common Shares, No Par Value | 842 | $8.16 | $7K | |
| John Paulson - Director | Grant or award | Common Shares, No Par Value | 7,659 | $8.16 | $62K | |
| Brett Icahn - Director | Grant or award | Common Shares, No Par Value | 4,059 | $8.16 | $33K | |
Recent BHC Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Lenar Aimee J. | Officer | 36,827 | $259K | View on EDGAR | |
| - | - | - | - |
BHC insider trading FAQ
What is the latest insider trade for BHC?
Bausch Health Companies Inc. (BHC) had 6 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for BHC runs to 57 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BHC stock?
No insider purchases of BHC were filed in the last 90 days. 5 purchases are on record for this company.
How many insiders are selling BHC stock?
1 insider sale of BHC was filed in the last 90 days, totaling $259K.
Where can I see BHC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BHC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John Paulson view on EDGAR
- - Sandra Leung view on EDGAR
- - Amy B. Wechsler view on EDGAR
- - Aimee J. Lenar view on EDGAR
- - Aimee J. Lenar view on EDGAR
- - Aimee J. Lenar view on EDGAR
- - Steven Hyosig Lee view on EDGAR
- - Amy B. Wechsler view on EDGAR
- - John Paulson view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BHC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BHC with a 7-day demo
- BHC on your watchlist
- Every BHC Form 4 filing on record
- Up to 3 months of BHC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
